Stelara
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.stelarainfo.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Stelara
STELARA offers treatment options for Crohn's Disease, Ulcerative Colitis, Plaque Psoriasis, and Psoriatic Arthritis. Their products are designed for adults and children aged 6 years and older who are experiencing moderate to severe symptoms. The company emphasizes patient choice and encourages individuals to take an active role in their treatment decisions. STELARA provides comprehensive information and resources for both patients and healthcare professionals.Explore more
Popular SearchesStelaraJanssen Biotech IncJanssen BiotechSTELARAinfo.comPlaque Psoriasis & Psoriatic ArthritisSIC Code 28,283NAICS Code 32,325Show moreStelara Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stelara your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Stelara, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Stelara is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Stelara
Click to see if Stelara had a recent Job posting/layoffs
Check if Stelara has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Stelara launches new products
Earning: See what the market has to say on Stelara recently announced quarterly report
Funding: Get notified immidiatlly once Stelara has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Stelara
Find 2 more new buyers
Compare Similar Companies to Stelara
Compare insights from companies similar to Stelara, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Stelara is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stelara is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stelara.
Stelara Tech Stack
A closer look at the technologies used by Stelara
See more technologies
Stelara News & Media
DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible
Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care Approval marks the twelfth indication for DARZALEX FASPRO® and fifth in the newly diagnosed setting, underscoring its...New Analyses Suggest Favorable Results for STELARA® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn's Disease and Ulcerative Colitis
SPRING HOUSE, Pa., Oct. 25, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn's disease (CD) and ulcerative colitis...STELARA® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, Pa., July 9, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult...Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn's Disease
SPRING HOUSE, Pa., May 23, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn's disease (CD) and ulcerative colitis (UC),1-4 including data from the SEAVUE study, the first...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stelara
Sign Up For FreeTo access detailed company insights
STELARA offers treatment options for Crohn's Disease, Ulcerative Colitis, Plaque Psoriasis, and Psoriatic Arthritis. Their products are designed for adults and children aged 6 years and older who are experiencing moderate to severe symptoms. The company emphasizes patient choice and encourages individuals to take an active role in their treatment d... Read More
